Childhood cancer in Iceland 1981-2006;Krabbamein hjá bönum á Íslandi árin 1981-2006

Laeknabladid

Volumn 96, Issue 1, 2010, Pages 21-26

  Oskarsson, T ^a   Jonsson, O G ^a   Kristinsson, J R ^a   Jonmundsson, G K ^a   Jonasson, J G ^a   Haraldsson, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73949150466     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: 10.17992/lbl.2010.01.04     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et.al. Cancer statistics, 2006. CA Cancer j Clin 2006; 56: 106-130
2. Ries LAG, Eisner MP, Kosary CL, et.al. Cancer Statistics Review, 1975-2002, SEER National Cancer Institute. http://seercancergov/csr/1975-2002. 2005.
3. ACCIS. National estimates of incidence rates standardized to world standard population age 0-14 and 0-19. Automated Childhood Cancer Information System. 2003.
4. G. Gustafsson MH, Å. Vernby. Childhood Cancer Incidence and Survival in Sweden 1984-2005. Report 2007 from the Swedish Childhood Cancer Registry. 2007.
5. Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics 2008; 121: 1470-1477
6. NOPHO. Childhood cancer in the Nordic Countries. 2008.
7. Jöasson JG, Tryggvad̈tir Le. Krabbamein á Íslandi - Upplýsingar úr Krabbameinsskrá fyrir tíabilio 1957-2006. Krabbameinsfél agi 2008.
8. Lanzkowsky P. Manual of Pediatric Hematology and Oncology. 4 útg. 2005.
9. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007; 121: 2233-2240
10. Olsen JH, Moller T, Anderson H, et al. Lifelong Cancer Incidence in 47 697 Patients Treated for Childhood Cancer in the Nordic Countries. J Natl Cancer Inst 2009; 101: 806-813
11. Hóm H, Jósson ÓG, p̈sson ÁV, et al. Greining, árangur meoferoar og síokomnar aukaverkanir æxla í miotaugakerfi í æsku. Lænablaoio 2002; 88: 21-27
12. Kristinsson VH, Kristinsson JR, Jómundsson GK, J ósson ÓG, pórsson ÁV, Haraldsson Á. Síokomnar og langvinnar aukaverkanir eftir hvíblæoismeofero í æsku. Læonablaoio 2002; 88: 13-18
13. Steliarova-Foucher E, Stiller C, Lacour B, P K. International Classification of Childhood Cancer, third edition. Cancer 2005; 103: 1457-1467
14. Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-1957). Sendai, Japan: Tohoku University School of Medicine. 1960.
15. National Cancer Institude (NCI) - Surveillance E, and End Results (SEER). SEER pediatric monograph 1975-1995. 1999.
16. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JWW. Cancer in children and adolescents in Europe: Developments over 20 years and future challenges. Eur J Cancer 2006; 42: 2183-2190
17. Miller RW, Young JL, Jr., Novakovic B. Childhood cancer. 1995; Cancer 75(1 Suppl): 395-405.
18. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nature Rev Cancer 2002; 2: 124-132
19. Rodriguez FJ, Perry A, Gutmann DH, et al. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 2008; 67: 240-249
20. Hasle H. Pattern of malignant disorders in individuals with Down?s syndrome. Lancet Oncology 2001; 7: 429-436
21. Gourlay WA, Johnson HW, Pantzar JT, McGillivray B, Crawford R, Nielsen WR. Gonadal tumors in disorders of sexual differentiation. Urology 1994; 43: 537-540
22. MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer 2007; 48: 453-459